No Data
No Data
Wells Fargo Maintains GoodRx(GDRX.US) With Buy Rating, Cuts Target Price to $7
Wells Fargo Maintains Overweight on GoodRx Holdings, Lowers Price Target to $7
TD Cowen Maintains GoodRx(GDRX.US) With Buy Rating, Maintains Target Price $8
TD Cowen Sticks to Their Buy Rating for GoodRx Holdings (GDRX)
We Think GoodRx Holdings (NASDAQ:GDRX) Can Manage Its Debt With Ease
Truist Financial Maintains GoodRx(GDRX.US) With Hold Rating, Announces Target Price $5.5